PRF Technologies (PRFX) Accumulated Expenses (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Accumulated Expenses of $1.9 million for Q4 2025, down 1.89% year-on-year from $1.9 million in Q4 2024, and up 2.02% on a QoQ basis from $1.8 million in Q2 2025.

PRF Technologies (PRFX) Accumulated Expenses (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Accumulated Expenses for 7 consecutive years, with $1.9 million the latest figure, recorded in Q4 2025.

  • Quarterly Accumulated Expenses fell 1.89% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 1.89% YoY) and the FY2025 annual result came in at $1.9 million, down 1.89% from the prior year.
  • Accumulated Expenses advanced to $1.9 million in Q4 2025 per PRFX's latest filing, from $1.8 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for PRFX reached as high as $4.3 million in Q2 2024 and fell as low as $53000.0 in Q2 2022.
  • A 5-year average of $998294.1 and a median of $499000.0 in 2022 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 90.47% — and 2024, when it soared 1513.56%.
  • Year by year, Accumulated Expenses stood at $423000.0 in 2021, then gained by 17.97% to $499000.0 in 2022, then tumbled by 76.35% to $118000.0 in 2023, then surged by 1513.56% to $1.9 million in 2024, then slipped by 1.89% to $1.9 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $1.9 million, $1.8 million, and $1.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 PRF Technologies 745,168.93 451,168.93 -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.87 Mn
Jun 30, 2025 1.83 Mn
Dec 31, 2024 1.90 Mn
Jun 30, 2024 4.28 Mn
Mar 31, 2024 2.47 Mn
Dec 31, 2023 118,000.00
Sep 30, 2023 460,000.00
Jun 30, 2023 525,000.00
Mar 31, 2023 437,000.00
Dec 31, 2022 499,000.00
Sep 30, 2022 395,000.00
Jun 30, 2022 53,000.00
Mar 31, 2022 121,000.00
Dec 31, 2021 423,000.00
Sep 30, 2021 457,000.00
Jun 30, 2021 556,000.00
Mar 31, 2021 582,000.00
Dec 31, 2020 149,000.00
Dec 31, 2019 151,000.00